September 11, 2012 — Data presented at the 2012 ESC Congress in Munich from the prospective DeFACTO study show that, when compared to standard coronary angiography, the noninvasive assessment of fractional flow reserve by computed tomography (FFR-CT) provides a more accurate determination of which lesions require invasive evaluation.


Sept. 10, 2012 – A mammography and women’s health advocacy group, Are You Dense Inc., blasted the American College of Radiology (ACR) and the Society of Breast Imaging (SBI) for their positions on recent research published in the Journal of the National Cancer Institute. The article detailed the risk of death by stage of cancer for women with breast cancer, which Are You Dense said is misleading in its presentation of data to the public.

Sept. 10, 2012 — High mammographic breast density, which is a marker of increased risk of developing breast cancer, does not seem to increase the risk of death among breast cancer patients, according to a study led by Gretchen L. Gierach, Ph.D., of the National Cancer Institute (NCI), part of the National Institutes of Health. The research was conducted in collaboration with investigators from the NCI-sponsored Breast Cancer Surveillance Consortium (BCSC).

September 10, 2012 — TeraRecon announced the launch of iNtuition Review, iNtuition Enterprise Medical Viewer (iEMV) and iNtuition Share. The software suite enhances the iNtuition portfolio with multimodality review solutions for advanced imaging, such as cardiac and breast procedures, with enterprise distribution and image sharing capability.

September 10, 2012 — In a recent study, researchers found that coffee consumption is inversely related to mortality, with consumption of greater than or equal to six cups of coffee per day associated with a 10 percent decreased mortality rate in men and 15 percent decreased mortality in women.

Solitaire Flow Restoration Device

September 7, 2012 — RaySearch Laboratories AB announces that version 3.0 of RaySearch’s RayStation treatment planning system has been released for clinical use in the European Union, United States, Japan and Australia, and is pending regulatory approval in Canada, China, New Zealand and South Korea.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now